Curewell Capital Majority Investment in Wilmington PharmaTech
October 21, 2025
Los Angeles-based private equity firm Curewell Capital has made a majority investment in Wilmington PharmaTech (WPT), a U.S.-based specialty CRDMO focused on small-molecule API development and manufacturing. Founder and CEO Hui-Yin "Harry" Li will retain a significant ownership stake and remain as CEO; the capital will be used to expand WPT's U.S. manufacturing capacity, including HPAPI suites, and scale end-to-end API development and manufacturing capabilities.
- Buyers
- Curewell Capital
- Targets
- Wilmington PharmaTech
- Industry
- Pharmaceuticals
- Location
- Delaware, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
WestView Capital Partners Invests Growth Capital in PharmaLink
July 21, 2025
Healthcare Services
WestView Capital Partners has made a growth investment in PharmaLink, a Largo, Florida–based pharmaceutical reverse logistics platform. The capital will support PharmaLink's expanded operations center, planned automation, and continued scaling of its return, recall and disposal services across the healthcare supply chain.
-
Ampersand Capital Partners Invests in Alliance Pharma
November 18, 2021
Healthcare Services
Ampersand Capital Partners has made a growth equity investment in Alliance Pharma, a Malvern, Pennsylvania–based bioanalytical CRO. The funding will support Alliance’s expansion of global reach, scientific capabilities, and operational capacity while founder Frank Li remains a significant shareholder.
-
1315 Capital Backs USpharma Ltd. with Growth Equity Investment
June 30, 2025
Pharmaceuticals
USpharma Ltd., a Miami Lakes-based pharmaceutical development and manufacturing company, received a growth equity investment from Philadelphia-based 1315 Capital. The capital will be used to accelerate development and commercialization of USpharma’s pipeline, expand commercial reach, and scale operations at its 150,000 sq. ft. US-based GMP facility.
-
Sole Source Capital Acquires Westwood Laboratories
October 17, 2022
Manufacturing
Sole Source Capital LLC, an industrial-focused private equity firm, has acquired Westwood Laboratories, a full-service contract manufacturer headquartered in Azusa, California that serves beauty, personal care, pet and over-the-counter drug brands. Five Points Capital provided unitranche debt and an equity co-invest to support the acquisition; terms were not disclosed.
-
424 Capital Makes Significant Investment in PTP
June 1, 2023
IT Services
424 Capital has completed a significant growth investment in PTP, a Norwood, Massachusetts-based cloud consulting and managed services firm focused on the life sciences. The capital will be used to expand PTP's capabilities and geographic presence to better serve biotechnology and therapeutics clients; Canaccord Genuity advised PTP on the transaction.
-
New State Capital Partners Takes Majority Stake in Wilmington Paper
November 12, 2021
Environmental Services
New State Capital Partners (via an affiliate) has made a majority equity investment in Wilmington Paper Corp., a recovered-fiber processor and intermediary headquartered in New Jersey. Management, led by CEO Stuart Lurie, retained a substantial minority stake; New State said it will support organic growth, technology and logistics investments, and pursue add-on acquisitions to extend the company's reach.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.